Evidence map›Paper›PMID 35323120›Full record

SynthesisJournal of medical Internet research2022

Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Lanlan Pang, Hengyu Liu, Zhidong Liu, Jinyu Tan, Long-Yuan Zhou, Yun Qiu, Xiaoqing Lin, Jinshen He, Xuehua Li, Sinan Lin and 3 more

Registry-linked trialOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06971627 (The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease), which is not on this map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06971627 narecruitingnot on this mapstarted 2024, after this paper: background citation

The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease

TypeinterventionalSponsorIstanbul University - CerrahpasaRan2024 to 2025Enrolled120ConditionsInflammatory Bowel Disease (IBD), Medication Compliance, Quality of Life, Telehealth MonitoringArmsNurse-led Telehealth Monitoring Program, No intervention
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. The impact of COVID-19 on inflammatory bowel disease surgery: a systematic review.Annals of the Royal College of Surgeons of England · 2026
    Pooled it
  2. Pooled it
  3. Psychological interventions for treatment of inflammatory bowel disease.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Lessons learned: telehealth for patients with eosinophilic gastrointestinal diseases.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Lanlan PangDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-4932-8117
Hengyu LiuZhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-2739-0032
Zhidong LiuZhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-3029-8317
Jinyu TanDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-8957-0522
Long-Yuan ZhouDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-3057-2566
Yun QiuDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-8466-8387
Xiaoqing LinDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0003-2875-8967
Jinshen HeDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-7559-5243
Xuehua LiDepartment of Radiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-7476-2644
Sinan LinDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-0977-9036
Subrata GhoshNIHR Biomedical Research Centre, Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.ORCID 0000-0002-1713-7797
Ren Mao *Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-5523-8185
Minhu Chen *Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0003-2421-9966
Sun Yat-sen University · CNUniversity Hospitals Birmingham NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTelemedicine plays an important role in the management of inflammatory bowel disease (IBD), particularly during a pandemic such as COVID-19. However, the effectiveness and efficiency of telemedicine in managing IBD are unclear.

objectiveThis systematic review and meta-analysis aimed to compare the impact of telemedicine with that of standard care on the management of IBD.

methodsWe systematically searched the PubMed, Cochrane Library, EMBASE, Web of Science, and Scopus databases on April 22, 2020. Randomized controlled trials comparing telemedicine with standard care in patients with IBD were included, while conference abstracts, letters, reviews, laboratory studies, and case reports were excluded. The IBD-specific quality of life (QoL), disease activity, and remission rate in patients with IBD were assessed as primary outcomes, and the number of in-person clinic visits per patient, patient satisfaction, psychological outcome, and medication adherence were assessed as secondary outcomes. Review Manage 5.3 and Stata 15.1 were used for data analysis.

resultsA total of 17 randomized controlled trials (2571 participants) were included in this meta-analysis. The telemedicine group had higher IBD-specific QoL than the standard care group (standard mean difference 0.18, 95% CI 0.01 to 0.34; P.03). The number of clinic visits per patient in the telemedicine group was significantly lower than that in the standard care group (standard mean difference -0.71, 95% CI -1.07 to -0.36; P<.001). Subgroup analysis showed that adolescents in the telemedicine group had significantly higher IBD-specific QoL than those in the standard care group (standard mean difference 0.42, 95% CI 0.15 to 0.69; I2=0; P.002), but there was no significant difference between adults in the 2 groups. There were no significant differences in disease activity, remission rate, patient satisfaction, depression, self-efficacy, generic QoL, and medication adherence outcomes between the telemedicine and standard care groups.

conclusionsTelemedicine intervention showed a promising role in improving IBD-specific QoL among adolescents and decreased the number of clinic visits among patients with IBD. Further research is warranted to identify the group of patients with IBD who would most benefit from telemedicine.

Indexed as

COVID-19Inflammatory Bowel DiseasesTelemedicineAdolescentAdultHumansQuality of LifeRandomized Controlled Trials as Topicdisease activityinflammatory bowel diseasemobile phonequality of lifetelemedicine

Identifiers

PMID35323120
PMCPMC8990345
OpenAlexW3207517854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.